Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

PTIX Protagenic Therapeutics

0.620
+0.010+1.64%
Close 09/29 16:00 ET
0.6200.0000.00%
Post Mkt Price 09/29 18:04 ET
High
0.670
Open
0.610
Turnover
10.77K
Low
0.600
Pre Close
0.610
Volume
17.42K
Market Cap
10.72M
P/E(TTM)
Loss
52wk High
2.350
Shares
17.29M
P/E(Static)
Loss
52wk Low
0.561
Float Cap
7.54M
Bid/Ask %
-66.67%
Historical High
4.890
Shs Float
12.16M
Volume Ratio
0.93
Historical Low
0.561
Dividend TTM
--
Div Yield TTM
--
P/B
1.30
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.14%
Amplitude
11.52%
Avg Price
0.618
Lot Size
1
Float Cap
7.54M
Bid/Ask %
-66.67%
Historical High
4.890
Shs Float
12.16M
Volume Ratio
0.93
Historical Low
0.561
Dividend TTM
--
P/B
1.30
Dividend LFY
--
Turnover Ratio
0.14%
Amplitude
11.52%
Avg Price
0.618
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Protagenic Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapeutics to treat stress-related disorders including post-traumatic stress disorder, depression, anxiety, and drug & alcohol addiction. The firm offers PT00114 peptide-based formulations. The company was founded by Garo H. Armen, David A. Lovejoy, and Hartoun Hartounian on February 3, 1994 and is headquartered in New York, NY.
CEO: Dr. Garo H. Armen, Pd.D
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...